Study Details
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Clinicaltrials.gov ID
Astellas Study ID
7487-CL-0209
EudraCT ID
2013-004076-34
Condition
Advanced/Metastatic Cancer
Phase
Phase 2
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Apr 2014 - Dec 2016
Masking
None (Open Label)
Enrollment number
13
A Phase II Open-label Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site TH66002
Songkhla, Thailand, 90110
Site SG65002
Singapore, Singapore, 308433
Site US10001
Oklahoma City, United States, 73104
Site US10002
Baltimore, United States, 21287
Site US10004
La Jolla, United States, 92093-0987
Site TH66003
Khon Kaen, Thailand, 40002
Site US10008
Ann Arbor, United States, 48109
Site DE49001
Wuerzburg, Germany, 97080
Site US10006
Tampa, United States, 33612
Site DE49002
Berlin, Germany, 10117
Site PL48001
Szczecin, Poland, 70-891
Site BR55005
Porto Alegre, Brazil, 90610-000
Site CZ42001
Ostrava-Poruba, Czech Republic, 70852